Mathes Company, Inc. - Organicell Regenerative Medecine, Inc. ownership

Organicell Regenerative Medecine, Inc.'s ticker is and the CUSIP is 68621D107. A total of 1 filers reported holding Organicell Regenerative Medecine, Inc. in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Mathes Company, Inc. ownership history of Organicell Regenerative Medecine, Inc.
ValueSharesWeighting
Q3 2023$10.0%30,0000.0%0.00%
Q2 2023$10.0%30,0000.0%0.00%
-100.0%
Q4 2022$1
-100.0%
30,0000.0%0.00%0.0%
Q3 2022$2,00030,0000.00%
Other shareholders
Organicell Regenerative Medecine, Inc. shareholders Q3 2023
NameSharesValueWeighting ↓
Mathes Company, Inc. 30,000$10.00%
View complete list of Organicell Regenerative Medecine, Inc. shareholders